← Back to IBRX

ImmunityBio, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 04/08/2026Mar 2026Filed 07/05/2026Sep 2025Filed 05/11/2025Jun 2025Filed 04/08/2026Mar 2025Filed 07/05/2026Sep 2024Filed 05/11/2025Jun 2024Filed 05/08/2025Mar 2024Filed 12/05/2025
$51$44$32$26$17$6.1$1$0
−$230−$633−$67−$93−$130−$86−$135−$134
−$0.22−$0.62−$0.07−$0.10−$0.15−$0.14−$0.20−$0.20
1,0501,027947888853698687673

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.